Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study highlights value of longer consults for discussing antibiotics
The Government's strategy aimed to slow the development and spread of AMR.
Scientists review the UK Government's five-year AMR strategy. 

Longer consults could provide vets with better opportunities to discuss prescribing antibiotics with pet owners, according to new research.

The study by the Royal Veterinary College (RVC) in partnership with the London School of Hygiene & Tropical Medicine reviewed the Government's five-year antimicrobial resistance (AMR) strategy from 2013-2018.

It found that by adopting a One Health approach, the Strategy has instilled a shared sense of responsibility for tackling AMR across the human and animal health sectors. Among their key findings include:

  • identifying the different stages in which the livestock sector is improving the way it uses antibiotics and records data, with some private industry groups and professional bodies demonstrating strong leadership in implementing the Strategy
  • the potential value in longer consultation times for veterinary surgeons, which will provide them with better opportunities to discuss prescribing antibiotics with pet owners
  • the need for more data, over a longer period, to assess the impact of the guidelines and voluntary efforts to reduce the use of antibiotics in animals
  • the need for greater collaboration with regards to the surveillance of AMR and the data on the use of antibiotics across animals and people, to allow for easier comparison in a One Health perspective.
     
The Government's Strategy aimed to slow the development and spread of AMR by focussing on three key aims: improving the knowledge and understanding of antimicrobial resistance, conserving and stewarding the effectiveness of existing treatments, and stimulating the development of new antibiotics, diagnostics and novel therapies.

In the study, researchers assessed the implementation of the Strategy in human and animal health across the UK, along with the interim findings provided to the Department of Health and Social Care in 2018.

Dr Barbara Haesler, RVC senior lecturer in agrihealth, said: “There are certainly still challenges ahead, and the RVC looks forward to working with our colleagues across academia and Government to identify the best way forward in the coming months and years so that we can tackle the worrying possibility of widespread antimicrobial resistance head on.”

Professor Nicholas Mays, director of the Policy Innovation and Evaluation Research Unit at the London School of Hygiene & Tropical Medicine, adds: "As well as highlighting the progress we have made in AMR data reporting, our research found that rapidly and cheaply distinguishing bacterial infections from viral infections in routine human and animal care still remains a challenge. We are delighted to have worked closely with RVC to highlight key areas of this complex problem."

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.